MDXG MiMedx Group, Inc.: Operatsion rentabellik

MiMedx Group, Inc. (MDXG) - korporativ logo

MiMedx Group, Inc. (MDXG) uchun operatsion marja tahlili biomateriallarni qayta ishlashning robotlashtirilgan liniyalari va lazer nazoratining joriy etilishi bilan bog'liq. -8.30 qiymati ushbu ko'rsatkichning so'nggi ma'lumotlarini ko'rsatadi. Platsenta mahsulotlarining klinika protokollariga integratsiyasi barqaror daromadni ta'minlaydi. Shu bilan birga, MiMedx Group, Inc. (MDXG) surunkali jarohatlarni davolash uchun innovatsion biologik membranalar ishlab chiqish orqali to'qimalarni regeneratsiya qilish standartini o'rnatishni maqsad qilgan.

mimedx.com (MDXG): Sotuvning operatsion marjasi 04.07.2022dan 19.11.2026gacha

MiMedx Group, Inc. kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:MiMedx Group, Inc., MDXG
MiMedx Corp asosiy tovari

Operatsion marja soliq yuklari va qarz majburiyatlarining ta'sirini hisobga olmagan holda, asosiy biznes operatsiyalarining samaradorligini o'lchaydi. Operatsion marja tendentsiyasi kompaniyaning daromadning har bir birligidan foyda olish qobiliyatini namoyish etadi. Ushbu ko'rsatkich operatsion daromadning umumiy daromadga nisbati sifatida hisoblanadi. MiMedx Group, Inc. (MDXG) uchun ushbu ko'rsatkichning barqarorligi kuchli R&D yadrosining saqlanishi va asosiy bioximiklar orasida ishchi kuchi almashinuvining pastligi bilan ta'minlanadi. Xodimlarning yuqori malakasi bevosita operatsion chidamlilikka aylanadi.

Raqobatdosh kompaniyalar

Operatsion rentabellik Ascendis|Madrigal Corp (MDGL) - Operatsion faoliyat rentabelligi|Operatsion rentabellik corcept.com (CORT)|Sotuvning operatsion marjasi rhythmtx.com RYTM|Operatsion marja AKRO (akerotx.com)|MTSR - Sotuvning operatsion marjasi|MLTX - Operatsion rentabellik|Operatsion foyda normasi CRNX (Crinetics Pharma)|NAMS (newamsterdampharma.com) - Sotuvning operatsion marjasi|SLNO (Soleno Therapeutics) - Operatsion rentabellik|FOLD (Amicus Therapeutics Inc) - Operatsion marja|Sotuvning operatsion rentabelligi 89bio Corp ETNB|Operatsion rentabellik Agios Corp (AGIO)|Sotuvning operatsion marjasi Structure Therapeutics GPCR|Rezolute Bio - Sotuvning operatsion marjasi|lexpharma.com (LXRX) - Sotuvning operatsion rentabelligi|MBX - Operatsion rentabellik|ALT (Altimmune) - Operatsion foyda bo'yicha sotuv rentabelligi|Aardvark Therapeutics Inc. (AARD) - Operatsion rentabellik|Sagimet - Operatsion foyda normasi|BIOA (BioAge Labs, Inc) - Operatsion marja|Operatsion marja biomeafusion.com|Operatsion marja QNCX|GUTS - Sotuvning operatsion rentabelligi|Operatsion marja VTVT (vTv Therapeutics)|ATPC - Sotuvning operatsion marjasi|PLUR - Operatsion rentabellik|Synlogic Inc. (SYBX) - Sotuvning operatsion marjasi|LPCN (Lipocine Inc) - Sotuvning operatsion marjasi|Matinas BioPharma Holdings, Inc. - Operatsion foyda normasi|SPRB (sprucebiosciences.com) - Operatsion marja|Operatsion rentabellik GLTO|Operatsion marja CTCX|Lumos Pharma, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ONVO (organovo.com)|Operatsion foyda bo'yicha marjinallik Radius Health